---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-004501"
form_type: "8-K"
ticker: "MGRX"
cik: "0001938046"
company_name: "MANGOCEUTICALS, INC."
filed_at: "2025-01-31T23:59:59+00:00"
generated_at: "2026-05-27T04:51:33.313395+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Mangoceuticals converts $500k debt to equity at $1.50/share; licenses Dermytol skin care for 650k shares

## Summary
- Entered First Amendment with MAAB Global to convert $500,000 debt into up to 333,334 shares at $1.50/share.
- Signed Master Distribution Agreement with Propre Energie for Dermytol® formulations; pays 650,000 restricted shares and 1% gross sales revenue.
- Assigned rights under two Epiq Scripts agreements to subsidiary M&P; CEO Jacob Cohen is 51% owner of Epiq Scripts.
- Entered LT Global Practice Management Service Agreement (CEO's wife's company) for virtual professionals at $1,800-$3,500 each.

## SEC filing metadata
- accession: 0001493152-25-004501
- form_type: 8-K
- ticker: MGRX
- cik: 0001938046
- company_name: MANGOCEUTICALS, INC.
- filed_at: 2025-01-31T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1938046/000149315225004501/0001493152-25-004501-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1938046/000149315225004501/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-004501
- JSON: https://secwatch.observer/filing/0001493152-25-004501.json
- Plain text: https://secwatch.observer/filing/0001493152-25-004501.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.